👏 Another #SISAQOL contribution at #ISOQOL 2026: turning recommendations into practice.
A key lesson from our symposium: recommendations are only the first step. Better PRO analysis in cancer #ClinicalTrials also requires practical tools, training and implementation support.
🔍 How do we turn complex PRO data into meaningful patient insights? At #ISOQOL 2026, @lisa_wintner shared the #SISAQOL recommendations for communicating trial results.
To truly empower patients in shared decision-making, data must be clear and meaningful for everyone.
@ISOQOL
📸 A look back at the #SISAQOL pilot in-person training in Zagreb!
Thank you to all participants & the faculty, who came together to exchange knowledge and share best practices for the implementation of PROs & #HRQoL in cancer #ClinicalTrials.
See you in 2027!
#SISAQOLtraining
🤝The #SISAQOL pilot in-person training starts today in Zagreb! Bringing together experts & participants to explore the implementation of SISAQOL recommendations for PROs & HRQoL in cancer #ClinicalTrials.
Looking forward to two days of learning & collaboration.
#SISAQOLtraining
🔍 #SISAQOL featured in new @IHIEurope project factsheet
The factsheet highlights our recommendations, tools and resources to improve how HRQoL and PRO data are analysed and reported in cancer clinical trials.
🔗 Read more: sisaqol.org/2026/06/17/sisaq…
#QualityofLife #CancerResearch
📰 New article from @IHIEurope highlighting the work of #SISAQOL on making quality of life measures in cancer clinical trials more meaningful & comparable.
A key step towards better use of PROs in research & decision‑making.
🔗 ihi.europa.eu/news-events/ne…
#ClinicalTrialsDay @EORTC
⏰ Final reminder – deadline extended!
Applications for the SISAQOL 2026 pilot in‑person training are now open until Friday 29 May.
Don't miss the opportunity to learn from key SISAQOL experts!
👉 Read more & apply here: sisaqol.org/sisaqol-training…
#SISAQOLtraining @EORTC @EORTC_QLG
⏰ Last chance to apply!
Applications for SISAQOL 2026 pilot in‑person training close 15 May.
📍 Zagreb | 🗓 22–23 Sept
Hands‑on training on implementing SISAQOL recommendations.
✅ Free (2026 pilot only) | Selection applies
👉 Apply now: sisaqol-imi.org/sisaqol-trai…
#SISAQOLtraining
📢 Registration open!
SISAQOL pilot in‑person training on 22–23 Sept 2026 | Zagreb 🇭🇷
Hands‑on training on PRO & HRQoL endpoints – from design to reporting, led by SISAQOL experts.
✔️Limited places – selection applies
👉Apply by 15 May
🔗sisaqol-imi.org/sisaqol-trai…
#SISAQOLtraining
📢 Big news! The SISAQOL-IMI paper is now published!
It sets new international standards for patient-reported outcomes in cancer clinical trials.
📖 Publication: doi.org/10.1016/S1470-2045(2…
🌐 Online tools: sisaqol-imi.org/outputs/
#SISAQOL #CancerResearch #PROs
@TheLancet
SISAQOL-IMI is at @ISPORorg Europe 2025 presenting two posters in Glasgow, Scotland 🏴
#isporeurope #isporeurope2025 #sisaqol #qualityoflife #patientreportedoutcomes
📍 Poster 2: PCR135 Improving Patient Involvement in Cancer Clinical Trials: Development of Plain Language Checklists Within the SISAQOL-IMI
Initiative.
🔸️ @sillytense from @MyelomaEurope on behalf of @WECANadvocate
We’re thrilled to announce that our consortium will be presenting the SISAQOL-IMI recommendations at the @RoyalStatSoc Conference 2025 in Edinburgh this September!
We can't wait to share our insights and engage in thought-provoking discussions.
Stay tuned for more details 📊📢
🚨 New Publication Alert! 🚨
Our latest publication in BMC Medical Research Methodology explores handling missing patient-reported outcome data in the presence of intercurrent events. Aligning analysis with the estimand framework is key! 📊
Read more: bmcmedresmethodol.biomedcent…
Early this month, we presented key highlights from the final SISAQOL-IMI recommendations.
We invite you to explore the executive summary about the public launch and the collaborative efforts that underpin this initiative lnkd.in/eQqWB2Pv
📢 Yesterday, SISAQOL-IMI officially launched its final recommendations for standardising patient-reported outcomes in cancer clinical trials! 🎉 A huge step toward better, more reliable data for patient-centered care.
Learn more: sisaqol-imi.org/2025/02/05/s…
IMI_SISAQOL retweeted
📢Today at the #SISAQOLIMI launch, MPE´s Silene ten Seldam will present on patient involvement and Plain Language Checklists for myeloma trial protocols.
MPE board member, Vincent Claus also attended and joined a panel on implementing the recommendations.




















